NCCN Asia Consensus Statement prostate cancer

17Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

The National Comprehensive Cancer Network, an NPO organization comprised of university hospitals and cancer centers in the US. The publication of clinical practice guidelines on the treatment, diagnosis, prevention and screening is one of important activities. Background factors of prostate cancer patients, such as the prevalence, age at the diagnosis and mortality are markedly different between Western countries and Asia. Thus, various factors should be taken into consideration at the treatment choice for individual patients. Experts from Asian countries were published as the Asia Consensus Statement. In this review, we explain important points of the Asia Consensus Statement such as differences in the epidemiological backgrounds of patients, differences in treatment options and differences in medical insurance systems.

Cite

CITATION STYLE

APA

Hinotsu, S., Namiki, M., Ozono, S., & Akaza, H. (2018, November 1). NCCN Asia Consensus Statement prostate cancer. Japanese Journal of Clinical Oncology. Oxford University Press. https://doi.org/10.1093/jjco/hyy116

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free